Symposia: Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Antibody Therapy, Combination therapy, Fundamental Science, Adult, Drug development, MPN, Translational Research, Assays, Genomics, Bioinformatics, CML, Hematopoiesis, Chronic Myeloid Malignancies, Diseases, Immune mechanism, Cell expansion, Therapy sequence, Treatment Considerations, Biological therapies, Immunology, Clinical procedures, White blood cell disorders, Biological Processes, Myeloid Malignancies, Emerging technologies, Monoclonal Antibody Therapy, Technology and Procedures, Study Population, Profiling, Human, Pathogenesis, Imaging, Measurable Residual Disease , Machine learning, Molecular testing, Omics technologies, Pathology
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Antibody Therapy, Combination therapy, Fundamental Science, Adult, Drug development, MPN, Translational Research, Assays, Genomics, Bioinformatics, CML, Hematopoiesis, Chronic Myeloid Malignancies, Diseases, Immune mechanism, Cell expansion, Therapy sequence, Treatment Considerations, Biological therapies, Immunology, Clinical procedures, White blood cell disorders, Biological Processes, Myeloid Malignancies, Emerging technologies, Monoclonal Antibody Therapy, Technology and Procedures, Study Population, Profiling, Human, Pathogenesis, Imaging, Measurable Residual Disease , Machine learning, Molecular testing, Omics technologies, Pathology
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH